Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Wound Care

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1735895

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1735895

Negative Pressure Wound Therapy Market by Product (Conventional, Single-use NPWT, Consumables, Accessories), Wound Type (Burns, Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospitals, Homecare) - Global Forecast to 2030

PUBLISHED:
PAGES: 249 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global negative pressure wound therapy market is projected to reach USD 3.84 billion by 2030 from USD 2.76 billion in 2025, at a CAGR of 6.9% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsProduct type, Wound type, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

This is due to the increasing rise of diabetic patients, rising cases of traumatic injuries and burn injuries, and the growing geriatric population, which drives market growth. Additionally, rising usage of simplified single-use devices is expected to impact market growth.

"The hospitals segment of the negative pressure wound therapy market, by end user, is expected to hold the largest position during the forecast period."

Based on the end user, the negative pressure wound therapy market is divided into home care settings, hospitals, and other end users. Among these, hospitals hold the largest market share in 2024. The need for advanced wound care products in hospitals has been further stimulated by the rising incidence of diabetic foot ulcers and post-operative wounds. Hospital visits for wound care have also increased as a result of the growing geriatric population with chronic illnesses, including diabetes and vascular diseases. Hospitals can treat wounds quickly and effectively due to established protocols, knowledgeable medical staff, and a wide range of traditional wound care materials. As a result of the increased focus on improving wound care practices and patient recovery rates, this market segment continues to hold its dominant position.

"The burns and surgical & open wounds accounted for the largest market share in the negative pressure wound therapy market."

The negative pressure wound therapy market is segmented into burns and surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds. The burns and surgical & open wounds segment accounted for the largest share in the negative pressure wound therapy market in 2024. Burns and surgical & open wounds are leading segments in the negative pressure wound therapy market due to their rising occurrence and complexity, which require advanced wound management solutions. NPWT devices are particularly effective in managing these types of wounds, as they promote quicker healing, reduce infection risk, and improve tissue regeneration. Surgical wounds involving large incisions or at risk of dehiscence benefit significantly from maintaining a clean, moist wound environment and reducing edema.

"Asia Pacific is the fastest-growing region of the negative pressure wound therapy market by region."

The global negative pressure wound therapy market is segmented into five segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific negative pressure wound therapy market is growing due to the geriatric population, rising healthcare costs, and a growing incidence of chronic wounds. Asia Pacific offers high growth opportunities for players in the market. This segment is slated to register the highest CAGR during the forecast period.

As the number of surgeries, road accidents, and burn cases increases, there is an increasing need for effective wound care therapies. The growing incidence of diabetes has led to a rise in diabetic foot ulcers, highlighting the significance of proper wound care. The expansion of the healthcare system, e-commerce, and pharmacies has made the negative pressure wound therapy product accessible than ever. As awareness of wound care improves and healthcare services advance, the demand for negative pressure wound therapy solutions in the Mexico region is expected to see continued growth.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1: 38%, Tier 2: 29%, and Tier 3: 33%
  • By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
  • By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3%

Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the negative pressure wound therapy market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), Molnlycke AB (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Avery Dennison Corporation (US), BenQ Materials Corporation (Taiwan), Double Medical Technology Inc. (China), Advanced Oxygen Therapy Inc. (US), and Carilex Medical (Taiwan).

Research Coverage

This report studies the negative pressure wound therapy market based on product type, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights on the following pointers:

  • Analysis of key drivers (booming geriatric population, increasing cases of traumatic injuries, growing prevalence of chronic diseases

rising incidence of burn injuries

and favorable government and industry initiatives and reimbursements), restraints (high cost of negative pressure wound devices,

and risks associated with use of negative pressure wound therapy products), opportunities (high growth opportunities in emerging economies

and growing usage of simplified single-use devices), challenges (availability of alternative therapies, and Limited awareness among healthcare providers)

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the negative pressure wound therapy market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the negative pressure wound therapy market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the negative pressure wound therapy market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
Show more
Product Code: MD 6656

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
      • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.2.1.3 Approach 3: Primary interviews
      • 2.2.1.4 Growth forecast
      • 2.2.1.5 CAGR projections
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
    • 2.4.1 STUDY-RELATED ASSUMPTIONS
    • 2.4.2 PARAMETRIC ASSUMPTIONS
    • 2.4.3 GROWTH RATE ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
  • 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NEGATIVE PRESSURE WOUND THERAPY MARKET OVERVIEW
  • 4.2 ASIA PACIFIC NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER AND COUNTRY
  • 4.3 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY KEY COUNTRY
  • 4.4 NEGATIVE PRESSURE WOUND THERAPY MARKET, REGIONAL MIX, 2025 VS. 2030

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Booming geriatric population
      • 5.2.1.2 Increasing cases of traumatic injuries
      • 5.2.1.3 Growing prevalence of chronic diseases
      • 5.2.1.4 Rising incidence of burn injuries
      • 5.2.1.5 Favorable government and industry initiatives and reimbursement policies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of negative pressure wound therapy devices
      • 5.2.2.2 Risks associated with use of negative pressure wound therapy products
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging economies
      • 5.2.3.2 Increasing use of simplified single-use devices
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Availability of alternative therapies
      • 5.2.4.2 Limited awareness among healthcare providers
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
    • 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
    • 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Vacuum-assisted Closure (VAC) Therapy
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Topical Oxygen Therapy
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Hyperbaric Oxygen Therapy
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 IMPORT DATA (HS CODE 901890)
    • 5.11.2 EXPORT DATA (HS CODE 901890)
  • 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.13 CASE STUDY ANALYSIS
    • 5.13.1 CASE STUDY 1: COMPLEX WOUND HEALING WITH TOPICAL NEGATIVE PRESSURE WOUND THERAPY
    • 5.13.2 CASE STUDY 2: NECROTIZING FASCIITIS MANAGED WITH NEGATIVE PRESSURE WOUND THERAPY FOR BETTER WOUND CLOSURE
    • 5.13.3 CASE STUDY 3: TREATMENT OF HARD-TO-HEAL WOUNDS WITH PORTABLE NEGATIVE PRESSURE WOUND THERAPY
  • 5.14 REGULATORY LANDSCAPE
    • 5.14.1 REGULATORY ANALYSIS
      • 5.14.1.1 North America
        • 5.14.1.1.1 US
        • 5.14.1.1.2 Canada
      • 5.14.1.2 Europe
        • 5.14.1.2.1 Germany
        • 5.14.1.2.2 UK
        • 5.14.1.2.3 France
      • 5.14.1.3 Asia Pacific
        • 5.14.1.3.1 China
        • 5.14.1.3.2 Japan
        • 5.14.1.3.3 India
      • 5.14.1.4 Latin America
      • 5.14.1.5 Middle East
    • 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.14.2.1 North America
      • 5.14.2.2 Europe
      • 5.14.2.3 Asia Pacific
      • 5.14.2.4 Latin America
      • 5.14.2.5 Rest of the World
  • 5.15 PORTER'S FIVE FORCES ANALYSIS
    • 5.15.1 BARGAINING POWER OF SUPPLIERS
    • 5.15.2 BARGAINING POWER OF BUYERS
    • 5.15.3 THREAT OF NEW ENTRANTS
    • 5.15.4 THREAT OF SUBSTITUTES
    • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 IMPACT OF AI ON NEGATIVE PRESSURE WOUND THERAPY MARKET
    • 5.17.1 INTRODUCTION
    • 5.17.2 MARKET POTENTIAL OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET
    • 5.17.3 AI USE CASES
    • 5.17.4 KEY COMPANIES IMPLEMENTING AI
    • 5.17.5 FUTURE OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET
  • 5.18 IMPACT OF US TARIFF REGULATION ON NEGATIVE PRESSURE WOUND THERAPY MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 KEY TARIFF RATES
    • 5.18.3 PRICE IMPACT ANALYSIS
    • 5.18.4 KEY IMPACT ON COUNTRY/REGION
      • 5.18.4.1 North America
      • 5.18.4.2 Europe
      • 5.18.4.3 Asia Pacific
    • 5.18.5 IMPACT ON END-USE INDUSTRIES
      • 5.18.5.1 Hospitals

6 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE

  • 6.1 INTRODUCTION
  • 6.2 CONVENTIONAL NPWT DEVICES
    • 6.2.1 RISING FOCUS ON EFFECTIVE WOUND MANAGEMENT TO EXPEDITE GROWTH
  • 6.3 SINGLE-USE NPWT DEVICES
    • 6.3.1 INCREASING ADOPTION OF SINGLE-USE DEVICES IN HOME HEALTHCARE TO PROMOTE GROWTH
  • 6.4 NPWT ACCESSORIES & CONSUMABLES
    • 6.4.1 GROWING PREVALENCE OF CHRONIC WOUNDS TO DRIVE MARKET

7 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE

  • 7.1 INTRODUCTION
  • 7.2 BURNS AND SURGICAL & OPEN WOUNDS
    • 7.2.1 HIGH INCIDENCE OF BURN INJURIES IN LOW AND MIDDLE-INCOME COUNTRIES TO AID GROWTH
  • 7.3 PRESSURE ULCERS
    • 7.3.1 INCREASING AGING POPULATION WORLDWIDE TO AUGMENT GROWTH
  • 7.4 DIABETIC FOOT ULCERS
    • 7.4.1 INCREASE PREVALENCE OF DIABETES TO STIMULATE GROWTH
  • 7.5 VENOUS LEG ULCERS
    • 7.5.1 RISING PREVALENCE OF OBESITY TO CONTRIBUTE TO GROWTH
  • 7.6 TRAUMATIC WOUNDS
    • 7.6.1 GROWING INCIDENCE OF TRAUMATIC INJURIES TO BOOST MARKET

8 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    • 8.2.1 RISING NUMBER OF SURGERIES TO ACCELERATE GROWTH
  • 8.3 HOME CARE SETTINGS
    • 8.3.1 INCREASING HEALTHCARE EXPENDITURE TO SPEED UP GROWTH
  • 8.4 OTHER END USERS

9 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 Rising regulatory approvals and favorable reimbursement policies to stimulate growth
    • 9.2.3 CANADA
      • 9.2.3.1 Increasing prevalence of diabetes to support growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 UK
      • 9.3.2.1 Increase in research & development activities to aid growth
    • 9.3.3 GERMANY
      • 9.3.3.1 Growing prevalence of hospital-acquired infections to propel market
    • 9.3.4 FRANCE
      • 9.3.4.1 Rise in healthcare budget to spur growth
    • 9.3.5 ITALY
      • 9.3.5.1 Increasing national healthcare funding to favor growth
    • 9.3.6 SPAIN
      • 9.3.6.1 Increasing number of surgical procedures to promote growth
    • 9.3.7 RUSSIA
      • 9.3.7.1 Escalating diabetes issue to drive market
    • 9.3.8 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 CHINA
      • 9.4.2.1 Increasing incidence of diabetic foot ulcers to encourage growth
    • 9.4.3 JAPAN
      • 9.4.3.1 Evolving healthcare delivery and infrastructure landscape to fuel market
    • 9.4.4 INDIA
      • 9.4.4.1 Booming medical tourism to speed up growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Growing focus on diabetes management to drive market
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Increasing awareness and focus on advanced wound care therapies to facilitate growth
    • 9.4.7 SINGAPORE
      • 9.4.7.1 Increasing healthcare spending to sustain growth
    • 9.4.8 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Free healthcare services to bolster growth
    • 9.5.3 MEXICO
      • 9.5.3.1 Expanding hospital infrastructure to aid growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NEGATIVE PRESSURE WOUND THERAPY MARKET
  • 10.3 REVENUE ANALYSIS, 2022-2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Product type footprint
      • 10.5.5.4 Wound type footprint
      • 10.5.5.5 End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of key startups/SMEs
  • 10.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 10.7.1 COMPANY VALUATION
    • 10.7.2 FINANCIAL METRICS
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS
    • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 SOLVENTUM
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches and approvals
        • 11.1.1.3.2 Other developments
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Key strengths
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 SMITH+NEPHEW
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches and approvals
        • 11.1.2.3.2 Deals
        • 11.1.2.3.3 Expansions
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Key strengths
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses and competitive threats
    • 11.1.3 CARDINAL HEALTH
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Deals
        • 11.1.3.3.2 Expansions
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Key strengths
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses and competitive threats
    • 11.1.4 MOLNLYCKE AB
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Deals
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Key strengths
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses and competitive threats
    • 11.1.5 CONVATEC GROUP PLC
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Deals
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Key strengths
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses and competitive threats
    • 11.1.6 PAUL HARTMANN AG
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Deals
    • 11.1.7 AVERY DENNISON CORPORATION
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Deals
        • 11.1.7.3.2 Expansions
    • 11.1.8 BENQ MATERIALS CORPORATION
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Deals
        • 11.1.8.3.2 Other developments
    • 11.1.9 ADVANCED OXYGEN THERAPY INC.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product launches and approvals
  • 11.2 OTHER PLAYERS
    • 11.2.1 DOUBLE MEDICAL TECHNOLOGY INC.
    • 11.2.2 CARILEX MEDICAL
    • 11.2.3 DEROYAL INDUSTRIES, INC.
    • 11.2.4 LOHMANN & RAUSCHER GMBH & CO. KG
    • 11.2.5 MEDAXIS LLC
    • 11.2.6 GENADYNE BIOTECHNOLOGIES, INC.
    • 11.2.7 DIRECT HEALTHCARE GROUP
    • 11.2.8 ALLEVA MEDICAL
    • 11.2.9 CORK MEDICAL, LLC
    • 11.2.10 PENSAR MEDICAL
    • 11.2.11 HAROMED
    • 11.2.12 GUANGZHOU RAINHOME PHARM & TECH CO., LTD.
    • 11.2.13 GUARD MEDICAL
    • 11.2.14 DATT MEDIPRODUCTS PRIVATE LIMITED
    • 11.2.15 KORAZON MEDICAL DEVICES PRIVATE LIMITED
    • 11.2.16 TRIAGE MEDITECH PVT. LTD.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Show more
Product Code: MD 6656

List of Tables

  • TABLE 1 NEGATIVE PRESSURE WOUND THERAPY MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 NEGATIVE PRESSURE WOUND THERAPY MARKET: RISK ASSESSMENT
  • TABLE 3 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023
  • TABLE 4 ROAD ACCIDENT DEMOGRAPHIC, 2022
  • TABLE 5 CHINA: STATES ON DISCHARGE OF PATIENTS WITH TYPE 2 DFU IN DIFFERENT AGE GROUPS, JANUARY 2017-DECEMBER 2023
  • TABLE 6 RISKS ASSOCIATED WITH NEGATIVE PRESSURE WOUND THERAPY DEVICES
  • TABLE 7 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023-2024
  • TABLE 8 AVERAGE SELLING PRICING TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, 2023-2025
  • TABLE 9 AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY KEY PLAYER, 2023-2025
  • TABLE 10 AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY REGION, 2023-2025
  • TABLE 11 NEGATIVE PRESSURE WOUND THERAPY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 12 NEGATIVE PRESSURE WOUND THERAPY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023-2024
  • TABLE 13 IMPORT DATA (HS CODE 901890), BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 14 EXPORT DATA (HS CODE 901890), BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 15 NEGATIVE PRESSURE WOUND THERAPY MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 16 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
  • TABLE 17 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS (%)
  • TABLE 24 KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
  • TABLE 25 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 26 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 27 KEY COMPANIES OFFERING CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES
  • TABLE 28 CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 29 NORTH AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 EUROPE: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 LATIN AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 KEY COMPANIES OFFERING SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES
  • TABLE 34 SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 NORTH AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 EUROPE: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 LATIN AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 KEY COMPANIES OFFERING NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES
  • TABLE 40 NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 41 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 EUROPE: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 46 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 PREVALENCE OF DIABETES, 2024
  • TABLE 57 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (THOUSANDS)
  • TABLE 58 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 70 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 73 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 74 HOSPITALS PER CAPITA, BY COUNTRY, 2025
  • TABLE 75 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 80 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 82 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 84 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 86 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 87 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 90 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 91 NORTH AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 92 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 96 US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 97 US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 98 US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 99 CANADA: ESTIMATED PREVALENCE OF DIABETES, 2023-2024
  • TABLE 100 CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 101 CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 102 CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 103 EUROPE: KEY MACROECONOMIC INDICATORS
  • TABLE 104 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 107 EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 108 UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 109 UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 110 UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 111 GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 113 GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 114 FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 116 FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 117 ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 118 ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 119 ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 120 SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 122 SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 123 RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 125 RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 126 REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 127 REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
  • TABLE 130 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 134 CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 136 CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 137 JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 140 INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 141 INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 143 AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 144 AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 145 AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 146 SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 149 SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 150 SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 151 SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 152 REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 153 REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 155 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 156 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 157 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 158 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 159 LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 160 BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 161 BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 163 MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 165 MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 166 REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 167 REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 168 REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
  • TABLE 170 MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023-2030 (USD MILLION)
  • TABLE 172 MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 173 NEGATIVE PRESSURE WOUND THERAPY MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2022-MARCH 2025
  • TABLE 174 NEGATIVE PRESSURE WOUND THERAPY MARKET: DEGREE OF COMPETITION
  • TABLE 175 NEGATIVE PRESSURE WOUND THERAPY MARKET: REGION FOOTPRINT
  • TABLE 176 NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 177 NEGATIVE PRESSURE WOUND THERAPY MARKET: WOUND TYPE FOOTPRINT
  • TABLE 178 NEGATIVE PRESSURE WOUND THERAPY MARKET: END-USER FOOTPRINT
  • TABLE 179 NEGATIVE PRESSURE WOUND THERAPY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 180 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 181 NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MARCH 2025
  • TABLE 182 NEGATIVE PRESSURE WOUND THERAPY MARKET: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 183 NEGATIVE PRESSURE WOUND THERAPY MARKET: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 184 NEGATIVE PRESSURE WOUND THERAPY MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
  • TABLE 185 SOLVENTUM: COMPANY OVERVIEW
  • TABLE 186 SOLVENTUM: PRODUCTS OFFERED
  • TABLE 187 SOLVENTUM: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MARCH 2025
  • TABLE 188 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
  • TABLE 189 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 190 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 191 SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MARCH 2025
  • TABLE 192 SMITH+NEPHEW: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 193 SMITH+NEPHEW: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 194 CARDINAL HEALTH: COMPANY OVERVIEW
  • TABLE 195 CARDINAL HEALTH: PRODUCTS OFFERED
  • TABLE 196 CARDINAL HEALTH: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 197 CARDINAL HEALTH: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 198 MOLNLYCKE AB: COMPANY OVERVIEW
  • TABLE 199 MOLNLYCKE AB: PRODUCTS OFFERED
  • TABLE 200 MOLNLYCKE AB: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 201 CONVATEC GROUP PLC: COMPANY OVERVIEW
  • TABLE 202 CONVATEC GROUP PLC: PRODUCTS OFFERED
  • TABLE 203 CONVATEC GROUP PLC: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 204 PAUL HARTMANN AG: COMPANY OVERVIEW
  • TABLE 205 PAUL HARTMANN AG: PRODUCTS OFFERED
  • TABLE 206 PAUL HARTMANN AG: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 207 AVERY DENNISON CORPORATION: COMPANY OVERVIEW
  • TABLE 208 AVERY DENNISON CORPORATION: PRODUCTS OFFERED
  • TABLE 209 AVERY DENNISON CORPORATION: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 210 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022-MARCH 2025
  • TABLE 211 BENQ MATERIALS CORPORATION: COMPANY OVERVIEW
  • TABLE 212 BENQ MATERIALS CORPORATION: PRODUCTS OFFERED
  • TABLE 213 BENQ MATERIALS CORPORATION: DEALS, JANUARY 2022-MARCH 2025
  • TABLE 214 BENQ MATERIALS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
  • TABLE 215 ADVANCED OXYGEN THERAPY INC.: COMPANY OVERVIEW
  • TABLE 216 ADVANCED OXYGEN THERAPY INC.: PRODUCTS OFFERED
  • TABLE 217 ADVANCED OXYGEN THERAPY INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MARCH 2025
  • TABLE 218 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW
  • TABLE 219 CARILEX MEDICAL: COMPANY OVERVIEW
  • TABLE 220 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW
  • TABLE 221 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 222 MEDAXIS LLC: COMPANY OVERVIEW
  • TABLE 223 GENADYNE BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 224 DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW
  • TABLE 225 ALLEVA MEDICAL: COMPANY OVERVIEW
  • TABLE 226 CORK MEDICAL, LLC: COMPANY OVERVIEW
  • TABLE 227 PENSAR MEDICAL: COMPANY OVERVIEW
  • TABLE 228 HAROMED: COMPANY OVERVIEW
  • TABLE 229 GUANGZHOU RAINHOME PHARM & TECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 230 GUARD MEDICAL: COMPANY OVERVIEW
  • TABLE 231 DATT MEDIPRODUCTS PRIVATE LIMITED: COMPANY OVERVIEW
  • TABLE 232 KORAZON MEDICAL DEVICES PRIVATE LIMITED: COMPANY OVERVIEW
  • TABLE 233 TRIAGE MEDITECH PVT. LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 NEGATIVE PRESSURE WOUND THERAPY MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 NEGATIVE PRESSURE WOUND THERAPY MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 NEGATIVE PRESSURE WOUND THERAPY MARKET: TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 9 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 10 NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF NEGATIVE PRESSURE WOUND THERAPY MARKET, 2025-2030
  • FIGURE 12 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
  • FIGURE 13 HOSPITALS SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024
  • FIGURE 14 CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030
  • FIGURE 15 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 16 NEGATIVE PRESSURE WOUND THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17 NEGATIVE PRESSURE WOUND THERAPY MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 18 NEGATIVE PRESSURE WOUND THERAPY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 19 NEGATIVE PRESSURE WOUND THERAPY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 20 NEGATIVE PRESSURE WOUND THERAPY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 21 NEGATIVE PRESSURE WOUND THERAPY MARKET: INVESTMENT AND FUNDING SCENARIO, 2019-2025
  • FIGURE 22 NEGATIVE PRESSURE WOUND THERAPY MARKET: PATENT ANALYSIS, JANUARY 2015-DECEMBER 2024
  • FIGURE 23 NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
  • FIGURE 25 KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
  • FIGURE 26 AI USE CASES
  • FIGURE 27 NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT
  • FIGURE 29 NEGATIVE PRESSURE WOUND THERAPY MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2022-2024
  • FIGURE 30 NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
  • FIGURE 31 RANKING OF KEY PLAYERS IN NEGATIVE PRESSURE WOUND THERAPY MARKET, 2024
  • FIGURE 32 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 33 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY FOOTPRINT
  • FIGURE 34 NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 36 EV/EBITDA OF KEY VENDORS
  • FIGURE 37 NEGATIVE PRESSURE WOUND THERAPY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 38 SOLVENTUM: COMPANY SNAPSHOT (2024)
  • FIGURE 39 SMITH+NEPHEW: COMPANY SNAPSHOT (2024)
  • FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
  • FIGURE 41 MOLNLYCKE AB: COMPANY SNAPSHOT (2024)
  • FIGURE 42 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 43 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024)
  • FIGURE 44 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 45 BENQ MATERIALS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 46 ADVANCED OXYGEN THERAPY INC.: COMPANY SNAPSHOT (2024)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!